Pharmaceuticals, Biotechnology and Life Sciences
– Presentation at World ADC Conference in San Diego – – CX-2051 integrates CytomX core platform expertise to potentially maximize…
Top-line findings will be presented Sept. 10 at the annual European Society for Medical Oncology (ESMO) Congress This is the…
Part A results from the two-part Phase 2 LILAC study show litifilimab significantly reduced disease activity based on active joint…
PRINCETON, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc., (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”),…
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
David Grand has Resigned as CEO and Chairman of the Company Effective Immediately to Pursue a New Role Involving Boundary…
Leverages Arcutis’ deep dermatology expertise and broad biologics experience to accelerate Ducentis’ lead compound, DS-234, in atopic dermatitisLead indication, atopic…
BUFFALO, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated…
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that…
Montrouge, France, September 7, 2022 DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch…